People · Operator

Aaron Fisher

Named in public records as an officer, director or promoter · active 2017–2021 · Retailing, Biotech, Biotechnology

3
Companies
3
Filings
$1.6M
Combined raised · real
Serial
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
EVPassport, Inc.RetailingPre-Seed$930K$6.0M2021
Empire Genomics Corp.BiotechPre-Seed$500K$16.7M2021
Envision Genomics, Inc.BiotechnologyPre-Seed$160K$8.8M2017
Operator network

Aaron Fisher at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Hooman Shahidi · 1 companies · 1 sharedHooman ShahidiMohammen Mehrabani · 1 companies · 1 sharedMohammen MehrabaniWilliam Snider · 7 companies · 1 sharedWilliam SniderJames Hudson · 2 companies · 1 sharedJames HudsonJason Chung · 2 companies · 1 sharedJason ChungBruce Korf · 1 companies · 1 sharedBruce KorfDavid Bick · 1 companies · 1 sharedDavid BickElizabeth Worthey · 1 companies · 1 sharedElizabeth WortheyGrace Terrell · 1 companies · 1 sharedGrace TerrellHoward Jacob · 1 companies · 1 sharedHoward JacobJill Tapper · 1 companies · 1 sharedJill TapperThomas Main · 1 companies · 1 sharedThomas MainEVPassport, Inc. · $0.9M raisedEVPassport, Inc.Empire Genomics Corp. · $0.5M raisedEmpire Genomics Corp.Envision Genomics, Inc. · $0.2M raisedEnvision Genomics, In…Aaron FisherAF
Aaron Fisher Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Aaron Fisher on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
William Snider17
James Hudson12
Jason Chung12
David Bick11
Elizabeth Worthey11
Bruce Korf11
Howard Jacob11
Thomas Main11
Jill Tapper11
Grace Terrell11
Hooman Shahidi11
Mohammen Mehrabani11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.